Lung Disease Experts to Meet at UC Oct. 1
Experts in a broad range of lung disorders and diseases will meet at the University of Cincinnati Saturday, Oct. 1, for the first Pulmonary and Critical Care Update.
Sponsored by UC College of Medicine, the pulmonary and critical care division of UCs
Department of Internal Medicine
and the American Lung Association of Ohio, the update will feature local and national leaders in pulmonary and critical care.
Attendees will get an overview of new diagnostic and treatment strategies for pulmonary and critical illnesses, including pulmonary hypertension, interstitial lung disease, lung cancer and obstructive lung disease.
Designed for pulmonary physicians, thoracic surgeons, internists, physicians in training, nurse practitioners and physician assistants, the update will provide seven category 1 continuing medical education credits.
The update runs from 7:30 a.m. to 4:30 p.m. at the Marriott Kingsgate Conference Hotel on UCs Academic Health Center campus.
Registration, limited to 60 participants, includes conference materials, breakfast and lunch. More information is available at
www.conferencing.uc.edu/pulmonary
or by calling (513) 558-1810.
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.